FAHIM RAAFAT E F 4
4 · NABI BIOPHARMACEUTICALS · Filed Apr 3, 2009
Insider Transaction Report
Form 4
FAHIM RAAFAT E F
DirectorPresident, CEO and CFO
Transactions
- Award
Common Stock
2009-04-01+45,000→ 270,063.534 total - Award
Stock Option (Right to Buy)
2009-04-01+115,000→ 115,000 totalExercise: $3.78Exp: 2016-04-01→ Common Stock (115,000 underlying)
Footnotes (2)
- [F1]Restricted Stock which vests in four equal annual installments beginning on April 1, 2010.
- [F2]The Option will become exercisable in four equal annual installments beginning on April 1, 2010.